Some recent studies have identified typical molecular alterations, such as MYC gene (8q24) amplification, as drivers of genetic profiles characterizing advanced stages of gastric tumors, with poor prognostic features [5–7]. The gene discussed is MYC; the disease is gastric neoplasm.